Johnson & Johnson (NYSE:JNJ) reported on Monday that its board of directors approved a common stock cash dividend of USD0.95 per share for the third quarter of 2019,the company .
With an ex-dividend date of 26 August 2019, the dividend will be paid on 10 September 2019 to shareholders of record at the close of business on 27 August 2019.
Johnson & Johnson together with its subsidiaries, researches and develops, manufactures and sells various products in the health care field worldwide. It operates in three segments: Consumer, Pharmaceutical and Medical Devices.
The company was incorporated in 1887 and is based in New Brunswick, New Jersey, USA.
Danaher Corporation announces quarterly cash dividend
Abbott announces quarterly common dividend
Bruker expands Preclinical Imaging Portfolio with acquisition of Spectral Instruments Imaging
Fusion Antibodies announces receipt of follow-on project and provides R&D update
Alvotech reports positive results for AVT03, potential biosimilar to Prolia and Xgeva